249 related articles for article (PubMed ID: 30907971)
1. Sex Differences in Rotenone Sensitivity Reflect the Male-to-Female Ratio in Human Parkinson's Disease Incidence.
De Miranda BR; Fazzari M; Rocha EM; Castro S; Greenamyre JT
Toxicol Sci; 2019 Jul; 170(1):133-143. PubMed ID: 30907971
[TBL] [Abstract][Full Text] [Related]
2. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
[TBL] [Abstract][Full Text] [Related]
3. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease.
Wu F; Xu HD; Guan JJ; Hou YS; Gu JH; Zhen XC; Qin ZH
Neuroscience; 2015 Jan; 284():900-911. PubMed ID: 25446361
[TBL] [Abstract][Full Text] [Related]
4. Noscapine Prevents Rotenone-Induced Neurotoxicity: Involvement of Oxidative Stress, Neuroinflammation and Autophagy Pathways.
Jayaraj RL; Beiram R; Azimullah S; M F NM; Ojha SK; Adem A; Jalal FY
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361780
[TBL] [Abstract][Full Text] [Related]
5. Selective microglial activation in the rat rotenone model of Parkinson's disease.
Sherer TB; Betarbet R; Kim JH; Greenamyre JT
Neurosci Lett; 2003 May; 341(2):87-90. PubMed ID: 12686372
[TBL] [Abstract][Full Text] [Related]
6. Role of L-thyroxin in counteracting rotenone induced neurotoxicity in rats.
Salama M; Helmy B; El-Gamal M; Reda A; Ellaithy A; Tantawy D; Mohamed M; El-Gamal A; Sheashaa H; Sobh M
Environ Toxicol Pharmacol; 2013 Mar; 35(2):270-7. PubMed ID: 23357603
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.
Sherer TB; Kim JH; Betarbet R; Greenamyre JT
Exp Neurol; 2003 Jan; 179(1):9-16. PubMed ID: 12504863
[TBL] [Abstract][Full Text] [Related]
8. Enhanced sensitivity of dopaminergic neurons to rotenone-induced toxicity with aging.
Phinney AL; Andringa G; Bol JG; Wolters ECh; van Muiswinkel FL; van Dam AM; Drukarch B
Parkinsonism Relat Disord; 2006 May; 12(4):228-38. PubMed ID: 16488175
[TBL] [Abstract][Full Text] [Related]
9. Immunoproteasome is up-regulated in rotenone-induced Parkinson's disease rat model.
Sun C; Jia G; Wang X; Wang Y; Liu Y
Neurosci Lett; 2020 Nov; 738():135360. PubMed ID: 32905834
[TBL] [Abstract][Full Text] [Related]
10. Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice.
Rocha SM; Bantle CM; Aboellail T; Chatterjee D; Smeyne RJ; Tjalkens RB
Neurobiol Dis; 2022 Jun; 167():105685. PubMed ID: 35257879
[TBL] [Abstract][Full Text] [Related]
11. Interaction between subclinical doses of the Parkinson's disease associated gene, α-synuclein, and the pesticide, rotenone, precipitates motor dysfunction and nigrostriatal neurodegeneration in rats.
Naughton C; O'Toole D; Kirik D; Dowd E
Behav Brain Res; 2017 Jan; 316():160-168. PubMed ID: 27585560
[TBL] [Abstract][Full Text] [Related]
12. Valeric Acid Protects Dopaminergic Neurons by Suppressing Oxidative Stress, Neuroinflammation and Modulating Autophagy Pathways.
Jayaraj RL; Beiram R; Azimullah S; Mf NM; Ojha SK; Adem A; Jalal FY
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081327
[TBL] [Abstract][Full Text] [Related]
13. Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson's Like Symptoms Without Loss of Dopaminergic Neurons.
Sharma M; Kaur J; Rakshe S; Sharma N; Khunt D; Khairnar A
Neurotox Res; 2022 Feb; 40(1):215-229. PubMed ID: 34817799
[TBL] [Abstract][Full Text] [Related]
14. Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model.
Salama RM; Tadros MG; Schaalan MF; Bahaa N; Abdel-Tawab AM; Khalifa AE
J Cell Physiol; 2018 Aug; 233(8):5981-6000. PubMed ID: 29266208
[TBL] [Abstract][Full Text] [Related]
15. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
Jayaraj RL; Beiram R; Azimullah S; Meeran MFN; Ojha SK; Adem A; Jalal FY
Molecules; 2019 Jun; 24(11):. PubMed ID: 31185705
[TBL] [Abstract][Full Text] [Related]
16. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model.
Zharikov AD; Cannon JR; Tapias V; Bai Q; Horowitz MP; Shah V; El Ayadi A; Hastings TG; Greenamyre JT; Burton EA
J Clin Invest; 2015 Jul; 125(7):2721-35. PubMed ID: 26075822
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
Carriere CH; Kang NH; Niles LP
Neuroscience; 2014 May; 267():114-21. PubMed ID: 24613722
[TBL] [Abstract][Full Text] [Related]
18. p38(MAPK)/p53-Mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson's disease.
Wu F; Wang Z; Gu JH; Ge JB; Liang ZQ; Qin ZH
Neurochem Int; 2013 Sep; 63(3):133-40. PubMed ID: 23714208
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of a standardized extract of Centella asiatica ECa233 in rotenone-induced parkinsonism rats.
Teerapattarakan N; Benya-Aphikul H; Tansawat R; Wanakhachornkrai O; Tantisira MH; Rodsiri R
Phytomedicine; 2018 May; 44():65-73. PubMed ID: 29895494
[TBL] [Abstract][Full Text] [Related]
20. Immunomorphological Changes in the Olfactory Bulbs of Rats after Intranasal Administration of Rotenone.
Voronkov DN; Kutukova KA; Ivanov MV; Khudoerkov RM
Bull Exp Biol Med; 2017 Dec; 164(2):203-206. PubMed ID: 29181664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
